Correction of hyperbilirubinemia in gunn rats using clinically relevant low doses of helper-dependent adenoviral vectors

Human Gene Therapy

Volumn 22, Issue 4, 2011, Pages 483-488

  Dimmock, David ^a,b   Brunetti Pierri, Nicola ^a,c   Palmer, Donna J ^a   Beaudet, Arthur L ^a   Ng, Philip ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GLUCURONOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRIGLER NAJJAR SYNDROME; FEMALE; GUNN RAT; HELPER VIRUS; HYPERBILIRUBINEMIA; MINIMALLY INVASIVE PROCEDURE; NONHUMAN; PROTEIN EXPRESSION; RAT;

ADENOVIRIDAE; ANIMALS; BILIRUBIN; CRIGLER-NAJJAR SYNDROME; DISEASE MODELS, ANIMAL; FEMALE; GENE ORDER; GENE THERAPY; GENETIC VECTORS; HYDRODYNAMICS; HYPERBILIRUBINEMIA; INJECTIONS, INTRAVENOUS; LIVER; PHENOTYPE; RATS; RATS, GUNN; TRANSDUCTION, GENETIC;

PRIMATES; RATTUS; RATTUS NORVEGICUS;

EID: 79954545857     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2010.167     Document Type: Article

References (20)

1. Brunetti-Pierri, N., Clarke, C., Mane, V., et al. (2008). Phenotypic correction of ornithine transcarbamylase deficiency using low dose helper-dependent adenoviral vectors. J. Gene Med. 10, 890-896.
2. Brunetti-Pierri, N., Palmer, D.J., Beaudet, A.L., et al. (2004). Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum. Gene Ther. 15, 35-46. (Pubitemid 38147187)
3. Brunetti-Pierri, N., Palmer, D.J., Mane, V., et al. (2005). Increased hepatic transduction with reduced systemic dissemination and proinflammatory cytokines following hydrodynamic injection of helper-dependent adenoviral vectors. Mol. Ther. 12, 99-106. (Pubitemid 40862361)
4. Brunetti-Pierri, N., Stapleton, G.E., Law, M., et al. (2009). Efficient, long-term hepatic gene transfer using clinically relevant HDAd doses by balloon occlusion catheter delivery in non-human primates. Mol. Ther. 17, 327-333.
5. Brunetti-Pierri, N., Stapleton, G.E., Palmer, D.J., et al. (2007). Pseudo-hydrodynamic delivery of helper-dependent adeno-viral vectors into non-human primates for liver-directed gene therapy. Mol. Ther. 15, 732-740. (Pubitemid 46431993)
6. Fox, I.J., Chowdhury, J.R., Kaufman, S.S., et al. (1998). Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 338, 1422-1426. (Pubitemid 28221983)
7. Jansen, P.L. (1999). Diagnosis and management of Crigler-Najjar syndrome. Eur. J. Pediatr. 158(Suppl 2), S89-S94.
8. Maruyama, H., Higuchi, N., Nishikawa, Y., et al. (2002). High-level expression of naked DNA delivered to rat liver via tail vein injection. J. Gene Med. 4, 333-341. (Pubitemid 40268369)
9. Meyburg, J., and Hoffmann, G.F. (2005). Liver transplantation for inborn errors of metabolism. Transplantation 80(1 Suppl), S135-S137. (Pubitemid 41552924)
10. Morral, N., O'Neal, W.K., Rice, K., et al. (2002). Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum. Gene Ther. 13, 143-154. (Pubitemid 34075178)
11. Nunes, F.A., Furth, E.E., Wilson, J.M., and Raper, S.E. (1999). Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: Safety of re-administration. Hum. Gene Ther. 10, 2515-2526. (Pubitemid 29489725)
12. Ozcay, F., Alehan, F., Sevmis, S., et al. (2009). Living related liver transplantation in Crigler-Najjar syndrome type 1. Transplant. Proc. 41, 2875-2877.
13. Palmer, D., and Ng, P. (2003). Improved system for helper-dependent adenoviral vector production. Mol. Ther. 8, 846-852. (Pubitemid 37527461)
14. Palmer, D.J., and Ng, P. (2004). Physical and infectious titers of helper-dependent adenoviral vectors: A method of direct comparison to the adenovirus reference material. Mol. Ther. 10, 792-798. (Pubitemid 39272868)
15. Palmer, D.J., and Ng, P. (2008). Methods for the production of first generation adenoviral vectors. Methods Mol. Biol. 433, 55-78.
16. Raper, S.E., Chirmule, N., Lee, F.S., et al. (2003). Fatal systemic inflammatory response syndrome in a ornithine transcarba-mylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80, 148-158. (Pubitemid 37272241)
17. Schauer, R., Stangl, M., Lang, T., et al. (2003). Treatment of Crigler-Najjar type 1 disease: Relevance of early liver transplantation. J. Pediatr. Surg. 38, 1227-1231. (Pubitemid 37048047)
18. Simonet, W.S., Bucay, N., Lauer, S.J., and Taylor, J.M. (1993). A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J. Biol. Chem. 268, 8221-8229. (Pubitemid 23120410)
19. Toietta, G., Mane, V.P., Norona, W.S., et al. (2005). Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. Proc. Natl. Acad. Sci. U.S.A. 102, 3930-3935. (Pubitemid 40388534)
20. Van der Veere, C.N., Sinaasappel, M., McDonagh, A.F., et al. (1996). Current therapy for Crigler-Najjar syndrome type 1: Report of a world registry. Hepatology 24, 311-315. (Pubitemid 26260025)